cbdMD, Inc. (YCBD)
Data as of , from SEC Form 4 filings.
See up to 3 months of YCBD. The 7-day demo opens the 1M and 3M ranges and puts YCBD on your watchlist.
Start 7-day demoLatest YCBD insider trades
About cbdMD, Inc. (YCBD)
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
- CHARLOTTE, NC
- 42
- 2017
- NYSE American
YCBD Form 4 activity by transaction type, last 90 days
No Form 4 activity for YCBD in the last 90 days.
YCBD insider transactions (Form 4)
108 Form 4 filings on record, the earliest from Dec 2, 2025, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Jeffrey H. Porter - Director | Grant or award | Common Stock | 1,572 | $0.00 | - | |
 Kevin Charles Roe - Director | Grant or award | Common Stock | 1,572 | $0.00 | - | |
 Sibyl Nichole Swift - Director | Grant or award | Common Stock | 1,572 | $0.00 | - | |
 Bakari T. Sellers - Director | Grant or award | Common Stock | 1,572 | $0.00 | - | |
 Scott G. Stephen - Director | Grant or award | Common Stock | 1,572 | $0.00 | - | |
 William F. Raines III - Director | Grant or award | Common Stock | 1,572 | $0.00 | - | |
| Clark R. Crosnoe - 10% Owner | Open-market sale | Common Stock | 461,725 | $2.31 | $1.07M | |
| Clark R. Crosnoe - 10% Owner | Open-market sale | Common Stock | 69,875 | $2.34 | $164K | |
| Clark R. Crosnoe - 10% Owner | Open-market sale | Common Stock | 19,101 | $2.34 | $45K | |
| Thomas Ronan Kennedy - Officer | Grant or award | Common Stock | 445,000 | - footnote F1 | - | |
| ||||||
YCBD insider trading FAQ
What is the latest insider trade for YCBD?
cbdMD, Inc. (YCBD) has filed no insider reports in the last 90 days. The most recent on record is dated 17 April 2026. The full record for YCBD runs to 8 Form 4 filings, the earliest from 2 December 2025. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying YCBD stock?
No insider purchases of YCBD were filed in the last 90 days.
How many insiders are selling YCBD stock?
No insider sales of YCBD were filed in the last 90 days. 3 sales are on record for this company.
Where can I see YCBD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects YCBD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Consumer Staples companies with insider activity
Recent insider filings
8The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jeffrey H. Porter view on EDGAR
- - Kevin Charles Roe view on EDGAR
- - Sibyl Nichole Swift view on EDGAR
- - Bakari T. Sellers view on EDGAR
- - Scott G. Stephen view on EDGAR
- - William F. Raines III view on EDGAR
- - Clark R. Crosnoe view on EDGAR
- - Thomas Ronan Kennedy view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Consumer Staples
- Where YCBD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow YCBD with a 7-day demo
- YCBD on your watchlist
- Every YCBD Form 4 filing on record
- Up to 3 months of YCBD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
